American Portfolios Advisors Sorrento Therapeutics, Inc. Transaction History

American Portfolios Advisors

  • $2.36 Trillion
  • Q3 2022

A detailed history of American Portfolios Advisors transactions in Sorrento Therapeutics, Inc. stock. As of the latest transaction made, American Portfolios Advisors holds 4,350 shares of SRNE stock, worth $1,435. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,350
Holding current value
$1,435
% of portfolio
0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Mar 17, 2023
BUY
$1.51 - $2.88 $6,568 - $12,528
4,350 New
4,350 $6.83 Million
Q4 2021

Mar 21, 2023
SELL
$4.65 - $7.23 $6,975 - $10,845
-1,500 Reduced 34.48%
2,850 $13.3 Million
Q3 2021

Mar 22, 2023
SELL
$7.41 - $10.99 $11,115 - $16,485
-1,500 Reduced 34.48%
2,850 $21.7 Million
Q2 2021

Mar 22, 2023
SELL
$6.35 - $10.0 $9,525 - $15,000
-1,500 Reduced 34.48%
2,850 $27.6 Million
Q1 2021

Mar 22, 2023
BUY
$7.03 - $16.51 $3,515 - $8,255
500 Added 11.49%
4,850 $40.1 Million
Q4 2020

Mar 22, 2023
BUY
$5.76 - $11.95 $7,488 - $15,534
1,300 Added 29.89%
5,650 $38.6 Million
Q3 2020

Mar 22, 2023
BUY
$6.17 - $18.82 $18,664 - $56,930
3,025 Added 69.54%
7,375 $82.2 Million
Q2 2020

Mar 24, 2023
BUY
$1.73 - $6.76 $1,859 - $7,267
1,075 Added 24.71%
5,425 $34.1 Million
Q1 2019

Mar 24, 2023
SELL
$1.86 - $5.94 $930 - $2,970
-500 Closed
0 $0
Q4 2018

Mar 24, 2023
SELL
$2.01 - $4.24 $2,009 - $4,240
-1,000 Reduced 66.67%
500 $1.2 Million
Q3 2018

Mar 24, 2023
SELL
$4.22 - $7.5 $12,027 - $21,375
-2,850 Reduced 65.52%
1,500 $6.6 Million
Q1 2018

Mar 24, 2023
SELL
$4.5 - $9.95 $12,825 - $28,357
-2,850 Reduced 65.52%
1,500 $7.73 Million
Q4 2017

Mar 24, 2023
SELL
$1.75 - $3.8 $4,112 - $8,930
-2,350
2,000 $7.6 Million

Others Institutions Holding SRNE

# of Institutions
12
Shares Held
5.47M
Call Options Held
0
Put Options Held
0
View Full List

About Sorrento Therapeutics, Inc.

SRNE Quotes by TradingView
  • Ticker SRNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 449,952,000
  • Market Cap $148M
  • Description
  • Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
More about SRNE
Track This Portfolio

Track American Portfolios Advisors Portfolio

Follow American Portfolios Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email